Hydroxychloroquine Drug
-
{
- All
- News
- Videos
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Brazil President Says He's Taking Hydroxychloroquine To Fight COVID-19
Brazilian President Jair Bolsonaro, who has tested positive for COVID-19, said on Facebook Thursday that he was "very well" and again advocated the use of the controversial drug hydroxychloroquine.
-
Trump Still Sees Hydroxychloroquine As Promising Virus Cure: White House
President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the US Food and Drug Administration has said its efficacy and safety were unproven.
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
Global COVID-19 Prevention Trial Of Hydroxychloroquine To Resume
A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Brazil President Says He's Taking Hydroxychloroquine To Fight COVID-19
Brazilian President Jair Bolsonaro, who has tested positive for COVID-19, said on Facebook Thursday that he was "very well" and again advocated the use of the controversial drug hydroxychloroquine.
-
Trump Still Sees Hydroxychloroquine As Promising Virus Cure: White House
President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the US Food and Drug Administration has said its efficacy and safety were unproven.
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
Global COVID-19 Prevention Trial Of Hydroxychloroquine To Resume
A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
